CMIC CMO USA CORPORATION

Form 483 issued May 4, 2021 · Cranbury, New Jersey

Inspection
May 4, 2021
Observations
2
Pages
3
FEI number
3001237056

In short: On May 4, 2021, FDA issued a Form 483 with 2 observations to CMIC CMO USA CORPORATION in Cranbury, New Jersey (FEI 3001237056) after an inspection that ran May 4, 2021. The investigators were Ankur C. Patel and Russell J. Glapion. Most observations concern production and facilities & equipment.

At a glance

Production and facilities & equipment account for 2 of 2 observations.

Production1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Time limits are not established when appropriate for the completion of each production phase to assure…

  2. 02

    Records are not kept for the maintenance and inspection of equipment. Electronic records are used, but…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at CMIC CMO USA CORPORATION?

FDA listed 2 observations on this Form 483, mostly about production and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected CMIC CMO USA CORPORATION?

Ankur C. Patel and Russell J. Glapion are named on this Form 483, for the inspection of May 4, 2021. Each investigator has a profile showing what they cite most.

When was CMIC CMO USA CORPORATION inspected by FDA?

The inspection ran May 4, 2021, and the Form 483 is dated May 4, 2021.

How do I get the full Form 483 for CMIC CMO USA CORPORATION?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free